Filing Flows › Medtronic (MDT) › Q4 FY25
Medtronic (MDT) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Jun 20, 2025
Medtronic (MDT) reported revenue of $8.9B for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +8% from the quarter before. Operating margin was 16.1%, net earnings $1.1B (11.8% of revenue).
Medtronic, Q4 FY25: revenue $8.9B (+4% year over year), operating margin 16.1%, net earnings $1.1B, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9B | +8% | +4% |
| Operating profit | $1.4B | -13% | +36% |
| Net earnings | $1.1B | -18% | +61% |
| Operating cash flow | $2.5B | -2% | -9% |
| Free cash flow | $2.1B | -1% | -12% |
What changed
Revenue was $8.9B in Q4 FY25, up 4% year over year and up 8% from the previous quarter.
Operating profit was $1.4B, a 16.1% margin (up 3.8 points year over year). Of the extra revenue versus a year earlier, 113% reached operating profit, above the 12% margin then. Total costs fell 1% while revenue rose 4%. Net earnings were $1.1B, up 61% year over year. The effective tax rate was 15.8%.
Operating cash flow was $2.5B (down 9% year over year), 238% of net earnings. Non-cash charges added back $0.84B of depreciation and amortization and $0.09B of share-based compensation. Working capital and other items added $0.54B. Capital expenditures of $0.46B left free cash flow of $2.1B.
Questions
What was Medtronic's revenue in the fourth quarter fiscal 2025?
Medtronic (MDT) reported revenue of $8.9B for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +8% from the quarter before.
Was Medtronic profitable in the fourth quarter fiscal 2025?
Operating profit was $1.4B (16.1% of revenue) and net earnings $1.1B.
Source: Medtronic 10-K on SEC EDGAR.